(71) revealed that ALKBH5 can promote osteosarcoma cell proliferation and tumor growth by decreasing the m6A modification of plasmacytoma variant translocation 1 (PVT1), subsequently impairing the binding of reader protein YTHDF2 in PVT1. Here, ALKBH5 is linked to osteosarcoma.